Assembly Biosciences, Inc. (ASMB)
31.74
+0.18
(+0.57%)
USD |
NASDAQ |
Jan 09, 16:00
31.82
+0.08
(+0.25%)
Pre-Market: 20:00
Assembly Biosciences Research and Development Expense (Annual): 55.80M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Gilead Sciences, Inc. | 5.816B |
| CorMedix, Inc. | 3.942M |
| Supernus Pharmaceuticals, Inc. | 106.36M |
| NovaBay Pharmaceuticals, Inc. | 0.042M |
| Palatin Technologies, Inc. | 14.90M |